Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
General Information
Revision date
2020-03-27
Product name
THERAFLU SINUS AND PAIN
Product Synonyms
THERAFLU FLU AND SORE THROAT POWDER FOR SOLUTION (PARACETAMOL 650MG + PHENIRAMINE MALEATE 20MG + PHENYLEPHRINE HYDROCHLORIDE 10MG) US * MFC1421
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Health hazards
Serious eye damage/eye irritation Category 2 H319 - Causes serious eye irritation. Skin sensitisation Category 1 H317 - May cause an allergic skin reaction. Hazard summary Caution - Pharmaceutical agent. Causes eye irritation. May cause an allergic skin reaction. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
NAT APPLE CINNAMON DURAROME, 860377 TD 0691, PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, Silicon dioxide
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation.
Prevention
P261 Avoid breathing dust. P264 Wash thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water/soap. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see instructions on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
4 % of the mixture consists of component(s) of unknown acute oral toxicity. 96,87 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 93,54 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 93,54 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards. Assume that this product is capable of sustaining combustion. Product may form explosive dust/air mixture if high concentration of product dust is suspended in air.
